Brief: Adial Advances To Second Cohort In Pharmacokinetics Study Of Ad04

Azora Therapeutics

23/07/2024 13:32

July 23 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS ADVANCES TO SECOND COHORT IN
PHARMACOKINETICS STUDY OF AD04 FOR THE TREATMENT OF ALCOHOL USE
DISORDER
    * ADIAL PHARMACEUTICALS INC: TOPLINE RESULTS FROM BOTH
COHORTS ARE
EXPECTED TO BE ANNOUNCED DURING Q4

Source text for Eikon:  ID:nGNX6JbcWc 
Further company coverage:  ADIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))